EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMixed-Methods-StudieOpen Access · CC BY 4.0

Diet strategies for maintaining substantial therapeutic weight loss: 78-week mixed methods randomised trial

Naomi Brosnahan, Catherine Hankey, Anthony Leeds, Wilma Leslie, George Thom, Lisa Hutchison, Lindsay Govan, Hazel Ross, Michael E J Lean

Clinical Nutrition · 2025

DOI: 10.1016/j.clnu.2025.08.009 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Nutrition, 2025. Verfasst von Naomi Brosnahan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Human Nutrition, School of Medicine, Dentistry and Nursing, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow Royal In…. Hauptthemen laut MEDLINE: Obesity, Weight Loss, Diet, Reducing, Caloric Restriction. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Dietetic Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND AIM: Formula low-energy diets (LED), used intermittently, may assist long-term weight-loss maintenance (WLM). This study compared total diet replacement 2 days/week (5:2TDR) and once-daily meal-replacements (DMR), delivered within a structured WLM programme. METHODS: A 78-week randomised trial was conducted in 63 individuals (75 % female, BMI 23-61 kg/m2), recruited between 12/04/2016 to 05/06/2018, after documented mean (SD) intentional weight-loss >8 kg, achieved using LED, behavioural programmes, or pharmacotherapy. Participants who had received anti-obesity medications were either weight stable or regaining after drug withdrawal. The primary outcome was weight change at 26-weeks following randomisation. Six dietitians and 25/63 (40 %) participants completed qualitative interviews at 26-weeks. Between-group differences were assessed using repeated ANCOVA adjusting for baseline values applying Intention-to-Treat, Per-Protocol, and As-Treated methods. RESULTS: At 26-weeks, 32/33 (97 %) randomised to 5:2TDR, and 29/30 (97 %) randomised to DMR, provided data. Four participants took pre-existing pharmacotherapy (n = 3 orlistat up to 78-weeks and n = 1 liraglutide up to 52-weeks). Mean (SD) pre-study weight-losses were similar between groups: 5:2TDR -15·0 (6·9) kg, DMR -18·8 (9·3) kg, p = 0.056. After 26-weeks WLM, intention-to-treat analysis found further weight-loss -0·9 kg (95 %CI -2·9, 1·5 kg) with 5:2TDR and regain with DMR 3·5 kg (95 %CI 1·3,5·5 kg); between-group difference -4·4 kg (95 %CI -7·3,-1·6 kg), p = 0·005. Maintained weight-losses at 26-weeks from pre-study start of weight loss were -15·8 (9·5) kg with 5:2TDR, -15·2 (10·5) kg with DMR, p = 0·977. Similar results were observed in the per protocol and as treated analyses. Both groups maintained weight losses >15 kg below baseline at 26, 52 and 78-weeks. Results were similar excluding those taking weight loss medications. Both interventions were well accepted. Dietitians successfully adapted LED interventions to overcome social/environmental challenges experienced by participants. CONCLUSIONS: Structured dietary WLM is well accepted and can prevent weight regain after substantial loss, including after glucagon-like peptide-1 agonist withdrawal, and can maintain >15 kg loss up to 78-weeks TRIAL REGISTRATION: Clinicaltrials.gov: identifier NCT02683798.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ObesityWeight LossDiet, ReducingCaloric RestrictionHumansFemaleMaleMiddle AgedAdultAnti-Obesity AgentsTreatment OutcomeFood, Formulated

Stichwörter der Autor:innen

Glucagon-like peptide 1HealthMeal replacementsNutritionObesityWeight loss maintenance

Substanzen

Anti-Obesity Agents

Autor:innen und Institutionen

  • Human Nutrition, School of Medicine, Dentistry and Nursing, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow Royal Infirmary, Glasgow, G31 2ER, Scotland, United Kingdom; Counterweight Ltd…
  • Human Nutrition, School of Medicine, Dentistry and Nursing, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow Royal Infirmary, Glasgow, G31 2ER, Scotland, United Kingdom.
  • Human Nutrition, School of Medicine, Dentistry and Nursing, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow Royal Infirmary, Glasgow, G31 2ER, Scotland, United Kingdom; The Parker Instit…
  • Counterweight Ltd, 85 Great Portland Street, First Floor, London, W1W 7LT, United Kingdom.

Förderung

  • British Dietetic Association

Zitieren

APA

Brosnahan, N., Hankey, C., Leeds, A., Leslie, W., Thom, G., Hutchison, L., Govan, L., Ross, H., & Lean, M. E. J. (2025). Diet strategies for maintaining substantial therapeutic weight loss: 78-week mixed methods randomised trial. Clinical Nutrition. https://doi.org/10.1016/j.clnu.2025.08.009

Vancouver

Brosnahan N, Hankey C, Leeds A, Leslie W, Thom G, Hutchison L, et al. Diet strategies for maintaining substantial therapeutic weight loss: 78-week mixed methods randomised trial. Clinical Nutrition. 2025. doi:10.1016/j.clnu.2025.08.009

BibTeX
@article{Brosnahan2025,
  author = {Brosnahan, Naomi and Hankey, Catherine and Leeds, Anthony and Leslie, Wilma and Thom, George and Hutchison, Lisa and Govan, Lindsay and Ross, Hazel and Lean, Michael E J},
  title = {Diet strategies for maintaining substantial therapeutic weight loss: 78-week mixed methods randomised trial},
  journal = {Clinical Nutrition},
  year = {2025},
  doi = {10.1016/j.clnu.2025.08.009}
}
Kostenlos starten →